Related Articles
Tumour growth and nitrogen metabolism in the host (Review).
The AP-1/NF-κB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia
Formoterol treatment down-regulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats
BARD1 content correlates with increased DNA fragmentation associated with muscle wasting in tumour-bearing rats
Effects of the PPARγ agonist GW1929 on muscle wasting in tumour-bearing mice